{
    "organizations": [],
    "uuid": "5d031eab3d85f29f8cd6265f03da7d94d23580da",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-chongqing-lummy-pharmaceutical-see/brief-chongqing-lummy-pharmaceutical-sees-fy-2018-q1-net-profit-up-96-59-pct-to-114-88-pct-idUSL3N1RN46D",
    "ord_in_thread": 0,
    "title": "BRIEF-Chongqing Lummy Pharmaceutical sees FY 2018 Q1 net profit up 96.59 pct to 114.88 pct",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 10(Reuters) - Chongqing Lummy Pharmaceutical Co Ltd :\n* Sees FY 2018 Q1 net profit to increase by 96.59 percent to 114.88 percent, or to be 43 million yuan to 47 million yuan\n* Says FY 2017 Q1 net profit was 21.9 million yuan\n* The reasons for the forecast are enhanced market promotion and contribution from stock investment return Source text in Chinese: goo.gl/4dV7KH Further company coverage: (Beijing Headline News)\n ",
    "published": "2018-04-10T18:37:00.000+03:00",
    "crawled": "2018-04-11T18:06:44.011+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "chongqing",
        "lummy",
        "pharmaceutical",
        "co",
        "ltd",
        "see",
        "fy",
        "q1",
        "net",
        "profit",
        "increase",
        "percent",
        "percent",
        "million",
        "yuan",
        "million",
        "yuan",
        "say",
        "fy",
        "q1",
        "net",
        "profit",
        "million",
        "yuan",
        "reason",
        "forecast",
        "enhanced",
        "market",
        "promotion",
        "contribution",
        "stock",
        "investment",
        "return",
        "source",
        "text",
        "chinese",
        "company",
        "coverage",
        "beijing",
        "headline",
        "news"
    ]
}